Suppr超能文献

精神分裂症的一级症状。

First rank symptoms for schizophrenia.

作者信息

Soares-Weiser Karla, Maayan Nicola, Bergman Hanna, Davenport Clare, Kirkham Amanda J, Grabowski Sarah, Adams Clive E

机构信息

Enhance Reviews Ltd, Central Office, Cobweb Buildings, The Lane, Lyford, Wantage, OX12 0EE, UK.

出版信息

Cochrane Database Syst Rev. 2015 Jan 25;1(1):CD010653. doi: 10.1002/14651858.CD010653.pub2.

Abstract

BACKGROUND

Early and accurate diagnosis and treatment of schizophrenia may have long-term advantages for the patient; the longer psychosis goes untreated the more severe the repercussions for relapse and recovery. If the correct diagnosis is not schizophrenia, but another psychotic disorder with some symptoms similar to schizophrenia, appropriate treatment might be delayed, with possible severe repercussions for the person involved and their family. There is widespread uncertainty about the diagnostic accuracy of First Rank Symptoms (FRS); we examined whether they are a useful diagnostic tool to differentiate schizophrenia from other psychotic disorders.

OBJECTIVES

To determine the diagnostic accuracy of one or multiple FRS for diagnosing schizophrenia, verified by clinical history and examination by a qualified professional (e.g. psychiatrists, nurses, social workers), with or without the use of operational criteria and checklists, in people thought to have non-organic psychotic symptoms.

SEARCH METHODS

We conducted searches in MEDLINE, EMBASE, and PsycInfo using OvidSP in April, June, July 2011 and December 2012. We also searched MEDION in December 2013.

SELECTION CRITERIA

We selected studies that consecutively enrolled or randomly selected adults and adolescents with symptoms of psychosis, and assessed the diagnostic accuracy of FRS for schizophrenia compared to history and clinical examination performed by a qualified professional, which may or may not involve the use of symptom checklists or based on operational criteria such as ICD and DSM.

DATA COLLECTION AND ANALYSIS

Two review authors independently screened all references for inclusion. Risk of bias in included studies were assessed using the QUADAS-2 instrument. We recorded the number of true positives (TP), true negatives (TN), false positives (FP), and false negatives (FN) for constructing a 2 x 2 table for each study or derived 2 x 2 data from reported summary statistics such as sensitivity, specificity, and/or likelihood ratios.

MAIN RESULTS

We included 21 studies with a total of 6253 participants (5515 were included in the analysis). Studies were conducted from 1974 to 2011, with 80% of the studies conducted in the 1970's, 1980's or 1990's. Most studies did not report study methods sufficiently and many had high applicability concerns. In 20 studies, FRS differentiated schizophrenia from all other diagnoses with a sensitivity of 57% (50.4% to 63.3%), and a specificity of 81.4% (74% to 87.1%) In seven studies, FRS differentiated schizophrenia from non-psychotic mental health disorders with a sensitivity of 61.8% (51.7% to 71%) and a specificity of 94.1% (88% to 97.2%). In sixteen studies, FRS differentiated schizophrenia from other types of psychosis with a sensitivity of 58% (50.3% to 65.3%) and a specificity of 74.7% (65.2% to 82.3%).

AUTHORS' CONCLUSIONS: The synthesis of old studies of limited quality in this review indicates that FRS correctly identifies people with schizophrenia 75% to 95% of the time. The use of FRS to diagnose schizophrenia in triage will incorrectly diagnose around five to 19 people in every 100 who have FRS as having schizophrenia and specialists will not agree with this diagnosis. These people will still merit specialist assessment and help due to the severity of disturbance in their behaviour and mental state. Again, with a sensitivity of FRS of 60%, reliance on FRS to diagnose schizophrenia in triage will not correctly diagnose around 40% of people that specialists will consider to have schizophrenia. Some of these people may experience a delay in getting appropriate treatment. Others, whom specialists will consider to have schizophrenia, could be prematurely discharged from care, if triage relies on the presence of FRS to diagnose schizophrenia. Empathetic, considerate use of FRS as a diagnostic aid - with known limitations - should avoid a good proportion of these errors.We hope that newer tests - to be included in future Cochrane reviews - will show better results. However, symptoms of first rank can still be helpful where newer tests are not available - a situation which applies to the initial screening of most people with suspected schizophrenia. FRS remain a simple, quick and useful clinical indicator for an illness of enormous clinical variability.

摘要

背景

精神分裂症的早期准确诊断和治疗可能对患者具有长期益处;精神病未得到治疗的时间越长,复发和康复的后果就越严重。如果正确诊断不是精神分裂症,而是另一种具有一些与精神分裂症相似症状的精神病性障碍,适当的治疗可能会延迟,这可能会给患者及其家人带来严重后果。对于一级症状(FRS)的诊断准确性存在广泛的不确定性;我们研究了它们是否是区分精神分裂症与其他精神病性障碍的有用诊断工具。

目的

确定一项或多项FRS对精神分裂症诊断的准确性,通过临床病史和合格专业人员(如精神科医生、护士、社会工作者)的检查进行验证,无论是否使用操作标准和检查表,针对被认为有非器质性精神病性症状的人群。

检索方法

我们于2011年4月、6月、7月及2012年12月使用OvidSP在MEDLINE、EMBASE和PsycInfo中进行检索。我们还于2013年12月检索了MEDION。

选择标准

我们选择了连续纳入或随机选择有精神病性症状的成年人及青少年的研究,并评估了与合格专业人员进行的病史和临床检查相比,FRS对精神分裂症的诊断准确性,这可能涉及或不涉及使用症状检查表或基于如ICD和DSM等操作标准。

数据收集与分析

两位综述作者独立筛选所有参考文献以确定是否纳入。使用QUADAS - 2工具评估纳入研究的偏倚风险。我们记录真阳性(TP)、真阴性(TN)、假阳性(FP)和假阴性(FN)的数量,为每项研究构建一个2×2表格,或从报告的汇总统计数据(如敏感性、特异性和/或似然比)中推导2×2数据。

主要结果

我们纳入了21项研究,共6253名参与者(5515名纳入分析)。研究时间为1974年至2011年,其中80%的研究在20世纪70年代、80年代或90年代进行。大多数研究未充分报告研究方法,许多研究存在较高的适用性问题。在20项研究中,FRS将精神分裂症与所有其他诊断区分开来,敏感性为57%(50.4%至63.3%),特异性为81.4%(74%至87.1%)。在7项研究中,FRS将精神分裂症与非精神病性心理健康障碍区分开来,敏感性为61.8%(51.7%至71%),特异性为94.1%(88%至97.2%)。在16项研究中,FRS将精神分裂症与其他类型的精神病区分开来,敏感性为58%(50.3%至65.3%),特异性为74.7%(65.2%至82.3%)。

作者结论

本综述中对质量有限的旧研究的综合分析表明,FRS在75%至95%的时间内能够正确识别精神分裂症患者。使用FRS在分诊中诊断精神分裂症时,每100名有FRS的人中约有5至19人会被错误诊断为精神分裂症,而专家不会认同此诊断。由于他们行为和精神状态的紊乱程度严重,这些人仍值得进行专家评估和帮助。同样,由于FRS的敏感性为60%,在分诊中依靠FRS诊断精神分裂症将无法正确诊断约40%专家认为患有精神分裂症的人。其中一些人可能会在获得适当治疗方面出现延迟。如果分诊依靠FRS的存在来诊断精神分裂症,其他专家认为患有精神分裂症的人可能会过早出院。在已知局限性的情况下,善解人意、谨慎地将FRS用作诊断辅助手段应能避免很大一部分此类错误。我们希望更新的测试——将纳入未来的Cochrane综述——会显示出更好的结果。然而,在没有更新测试的情况下——这适用于大多数疑似精神分裂症患者的初始筛查——一级症状仍然可能有用。FRS仍然是一种针对临床变异性极大的疾病的简单、快速且有用的临床指标。

相似文献

1
First rank symptoms for schizophrenia.
Cochrane Database Syst Rev. 2015 Jan 25;1(1):CD010653. doi: 10.1002/14651858.CD010653.pub2.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
3
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD011021. doi: 10.1002/14651858.CD011021.pub2.
4
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
5
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
6
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
Non-invasive diagnostic tests for Helicobacter pylori infection.
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD012080. doi: 10.1002/14651858.CD012080.pub2.
9
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
10
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.

引用本文的文献

2
Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia.
BMC Psychiatry. 2025 Mar 7;25(1):210. doi: 10.1186/s12888-025-06659-w.
3
Current Findings and Potential Mechanisms of KarXT (Xanomeline-Trospium) in Schizophrenia Treatment.
Clin Drug Investig. 2024 Jul;44(7):471-493. doi: 10.1007/s40261-024-01377-9. Epub 2024 Jun 21.
4
Self-disorder explained: Yasunaga's "Phantom Space Theory" on schizophrenia.
PCN Rep. 2023 Apr 27;2(2):e90. doi: 10.1002/pcn5.90. eCollection 2023 Jun.
5
On the concept of delusions: Global trends and psychopathology in Japan.
PCN Rep. 2023 Aug 8;2(3):e126. doi: 10.1002/pcn5.126. eCollection 2023 Sep.
8
The Nature of the Familial Risk for Psychosis in Bipolar Disorder.
Schizophr Bull. 2024 Jan 1;50(1):157-165. doi: 10.1093/schbul/sbad097.
9
Neurological Soft Signs in Schizophrenia, a Picture of the Knowledge in the Last Decade: A Scoping Review.
Healthcare (Basel). 2023 May 18;11(10):1471. doi: 10.3390/healthcare11101471.
10
Consciousness, (meta)cognition, and culture.
Q J Exp Psychol (Hove). 2023 Aug;76(8):1711-1723. doi: 10.1177/17470218231164502. Epub 2023 Apr 3.

本文引用的文献

1
Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis.
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD011021. doi: 10.1002/14651858.CD011021.pub2.
2
Schizophrenia and other psychotic disorders in DSM-5.
Clin Schizophr Relat Psychoses. 2013 Apr;7(1):16-9. doi: 10.3371/CSRP.TA.032513.
3
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009.
4
Prognostic variables in schizophrenia.
Indian J Psychiatry. 1989 Jan;31(1):51-62.
6
Early intervention for psychosis.
Cochrane Database Syst Rev. 2011 Jun 15(6):CD004718. doi: 10.1002/14651858.CD004718.pub3.
7
Concordance between chart review and structured interview assessments of schizophrenic symptoms.
Compr Psychiatry. 2012 Apr;53(3):275-9. doi: 10.1016/j.comppsych.2011.04.006. Epub 2011 Jun 12.
8
Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
Compr Psychiatry. 2011 Mar-Apr;52(2):126-31. doi: 10.1016/j.comppsych.2010.06.005. Epub 2010 Sep 9.
9
First rank symptoms in first episode psychosis and their relationship to the duration of untreated illness.
J Nerv Ment Dis. 2010 Nov;198(11):820-3. doi: 10.1097/NMD.0b013e3181f97c29.
10
Suicide and schizophrenia: a systematic review of rates and risk factors.
J Psychopharmacol. 2010 Nov;24(4 Suppl):81-90. doi: 10.1177/1359786810385490.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验